Intra-Cellular Therapies Inc (ITCI)
68.80
-1.54
(-2.19%)
USD |
NASDAQ |
May 03, 16:00
68.82
+0.02
(+0.02%)
After-Hours: 20:00
Intra-Cellular Therapies Accounts Payable (Quarterly): 11.45M for Dec. 31, 2023
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 11.45M |
September 30, 2023 | 10.61M |
June 30, 2023 | 7.733M |
March 31, 2023 | 8.441M |
December 31, 2022 | 10.40M |
September 30, 2022 | 14.22M |
June 30, 2022 | 10.75M |
March 31, 2022 | 11.65M |
December 31, 2021 | 8.691M |
September 30, 2021 | 12.03M |
June 30, 2021 | 15.94M |
March 31, 2021 | 8.721M |
December 31, 2020 | 5.502M |
September 30, 2020 | 8.569M |
June 30, 2020 | 5.473M |
March 31, 2020 | 10.99M |
December 31, 2019 | 7.425M |
September 30, 2019 | 6.231M |
June 30, 2019 | 5.633M |
March 31, 2019 | 8.574M |
December 31, 2018 | 13.96M |
Date | Value |
---|---|
September 30, 2018 | 10.45M |
June 30, 2018 | 5.379M |
March 31, 2018 | 10.04M |
December 31, 2017 | 6.174M |
September 30, 2017 | 4.408M |
June 30, 2017 | 1.775M |
March 31, 2017 | 7.158M |
December 31, 2016 | 3.755M |
September 30, 2016 | 5.418M |
June 30, 2016 | 3.890M |
March 31, 2016 | 1.959M |
December 31, 2015 | 1.633M |
September 30, 2015 | 0.705M |
June 30, 2015 | 4.911M |
March 31, 2015 | 4.574M |
December 31, 2014 | 2.053M |
September 30, 2014 | 0.5039M |
June 30, 2014 | 0.4158M |
March 31, 2014 | 2.143M |
December 31, 2013 | 3.395M |
September 30, 2013 | 4.027M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
5.473M
Minimum
Jun 2020
15.94M
Maximum
Jun 2021
9.498M
Average
8.721M
Median
Mar 2021
Accounts Payable (Quarterly) Benchmarks
Johnson & Johnson | 8.174B |
Insmed Inc | 65.39M |
Vertex Pharmaceuticals Inc | 364.90M |
Fate Therapeutics Inc | 4.719M |
ADMA Biologics Inc | 15.66M |